Currently predicting for Mon, 9 Dec 2024

Trading levels for CLDX

Fibonacci Support & Resistance Levels

Level Price
R3 27.68 3.41%
R2 27.27 1.88%
R1 27.02 0.94%
Price 26.77
S1 26.20 -2.11%
S2 25.95 -3.06%
S3 25.54 -4.58%

Accumulated Volume Support & Resistance Levels

Level Price
R3 32.86 22.75%
R2 27.63 3.21%
R1 26.86 0.336%
Price 26.77
S1 26.22 -2.05%
S2 26.06 -2.65%
S3 25.43 -5.01%

CLDX Predictions History

3 years ago
JS predicted that CLDX for 2021-02-01 is going $21.03 (-2.28%)

4 years ago
JS predicted that CLDX for 2020-04-16 is going $1.94 (2.65%)

4 years ago
تراحيب العتيبي predicted that CLDX for 2020-04-16 is going

Rank:

4 years ago
JS predicted that CLDX for 2020-04-06 is going $1.77 (1.72%)

4 years ago
Michael Tyler predicted that CLDX for 2020-04-06 is going $1.72 (-0.58%)

5 years ago
NameNotImportant predicted that CLDX for 2019-05-06 is going $10.41 (162.88%)

5 years ago
NameNotImportant predicted that CLDX for 2019-04-22 is going $3.64 (-3.96%)

5 years ago
PumpTheseNumbers predicted that CLDX for 2019-03-21 is going $5.08 (-1.17%)

5 years ago
JS predicted that CLDX for 2019-02-19 is going $5.73 (-2.22%)

5 years ago
Gp predicted that CLDX for 2019-02-19 is going $5.44 (-7.17%)

Click to get the best stock tips daily for free!
ABOUT CELLDEX THERAPEUTICS
Celldex Therapeutics
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-0159, a Phase I monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity...
GOLDEN STAR
Ticker Change Signal Date
NYT
$54.61
2.98% Dec 04
V
VCSH
$78.49
0.140% Dec 04
V
VGSH
$58.30
0.103% Dec 04
S
SLQD
$49.95
0.160% Dec 04
I
ISTB
$48.00
0.208% Dec 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE